GlassScriptPhysician profile
Sheri M Puffer
NPI 1215100656
$19,260.45
in general payments reported to CMS, 2019-2025
42 companies · $804 in 2025
The $804 reported for 2025 was more than what 88% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,176 · 2020: $624 · 2021: $11K · 2022: $4,678 · 2023: $894 · 2024: $388 · 2025: $804.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,014 · Education: $72.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,013.83 |
| Education | $72.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $15,135.32 | 2019-2024 | Da Vinci Surgical System |
| Exeltis, USA INC. | $519.93 | 2020-2025 | Slynd |
| Abbvie INC. | $470.30 | 2019-2025 | |
| Astellas Pharma US INC | $396.58 | 2022-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $327.35 | 2021-2025 | |
| Hologic Sales and Service, LLC | $310.62 | 2019-2024 | Novasure, Myosure Tissue Removal Device |
| Shield Therapeutics INC | $210.51 | 2022-2025 | Accrufer |
| Millicent US INC | $202.23 | 2020-2025 | Femlyv, Intrarosa |
| Agile Therapeutics, INC. | $160.25 | 2021-2024 | Twirla |
| Therapeuticsmd, INC. | $142.02 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $134.45 | 2019-2025 | |
| Daiichi Sankyo INC. | $127.76 | 2020-2023 | Injectafer |
| Sumitomo Pharma America, INC. | $116.90 | 2023-2024 | Myfembree |
| Avion Pharmaceuticals | $109.11 | 2019-2020 | |
| Pfizer INC. | $101.11 | 2021-2022 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheri Puffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.